Understanding the double-edge sword of steroids
Glucocorticoids are a type of steroid hormone that are used to treat everything from asthma to arthritis, but the impact of these powerful anti-inflammatory drugs particularly in prolonged, low-doses remains to be fully understood.
Now researchers from Flinders University are on a mission to find out how long-term steroid treatment for arthritis and pituitary tumours affect the bodys metabolic and cardiovascular mechanisms.
Between half and one per cent of the countrys population take steroids, or about 1000 people in South Australia, with the over 50s the most common consumer.
Research has already proven that high doses of steroids can cause diabetes, heart disease and weight gain but most patients are treated with low doses over a long period of time, chief investigator Dr. Morton Burt (pictured), a senior lecturer in the School of Medicine, said.
Yet theres less evidence on the effects of low-dose steroid therapy, he said.
So what we want to know is whether steroids mainly reduce insulin production or make the body resistant to insulin.
Without sufficient insulin the body cant reduce glucose and too much glucose in the blood causes diabetes.
Dr. Burts preliminary studies have shown that therapeutic doses of steroids only increase blood glucose after eating. After eating most glucose is taken up into muscle. This suggests steroids may predominantly cause insulin resistance in muscle.
So far Dr. Burt has performed detailed metabolic studies on about a dozen people before and one week after commencing steroid treatment and has also studied a similar number who have been taking steroids for a long period of time.
We give patients an injection of insulin to measure how much insulin they secrete over a 60 minute period, Dr. Burt said.
Subjects also have a six hour infusion of insulin and glucose to measure how resistant they are to insulin and whether the resistance is in the liver or muscle or both.
In another study, Dr. Burt is studying patients with pituitary tumours to determine what impact a higher or lower dose of steroids has on their risk of heart disease.
For most of us, our blood vessels become more relaxed after eating but our hypothesis is that this will not happen in people who are using steroid therapy.
Dr Burt, an endocrinologist at Southern Adelaide Diabetes and Endocrine Services, said the aim of his research is to develop new treatments that reduce the risk of heart disease in people who have steroid-induced diabetes.
Steroids are crucial in the treatment of many chronic diseases, yet they also have harmful side-effects. So if we can better understand these effects it will pave the way for therapies that specifically reverse the major metabolic abnormalities they induce and reduce cardiovascular risk.
Dr. Burt is supported by a South Australian Health Practitioner Fellowship and recently won a Flinders Universitys 2011 Vice-Chancellors Awards for Early Career Researchers.
He and Dr. Elke Sokoya, a senior lecturer in human physiology in the School of Medicine, each have won $39,770 in research funding in the latest Diabetes Australia Research Trust Awards.
Provided by Flinders University
- Pressure to look more muscular may lead some men to consider steroids Jun 03, 2011 | not rated yet | 0
- Well-controlled HIV doesn't affect heart metabolism, function Jan 26, 2012 | not rated yet | 0
- Scientists find missing link in regulation of glucose Dec 22, 2011 | not rated yet | 0
- Could a drug reverse Type 2 diabetes? Sep 23, 2011 | not rated yet | 0
- Researchers study biofeedback for asthma Nov 22, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
Medical research 11 hours ago | 5 / 5 (2) | 0 |
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research May 17, 2013 | 4 / 5 (4) | 0 |
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research May 17, 2013 | 5 / 5 (1) | 0
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research May 17, 2013 | 4 / 5 (1) | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
10 hours ago | not rated yet | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
11 hours ago | 4.8 / 5 (4) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
10 hours ago | 5 / 5 (2) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
15 hours ago | not rated yet | 0
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
10 hours ago | not rated yet | 0
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
22 hours ago | 4.8 / 5 (5) | 1 |